What is it about?
Reduction of cardiovascular (CV) risks factors, such as hypercholesterolemia is one of the most effective means of improving outcomes in patients with coronary heart disease (CHD). The effects of statin therapy on prevention of major CV events and cardiovascular disease (CVD) mortality have been established. This study presents detailed characteristics of primary care patients (e.g., using, or not using statins), who achieved, or did not achieve goals of lipid-lowering therapy.
Featured Image
Why is it important?
Achieving therapeutic targets for lipid fractions is crucial, among primary care patients, who are at risk for CVD. Large studies, conducted in out-patient setting, such as this one, are relatively uncommon. This study findings provide some valuable suggestions for improving the management of dyslipidemia.
Perspectives
There is an urgent need to effectively apply the lipid-lowering therapy (e.g., a combination of pharmacologic treatment and lifestyle changes) in primary care. Family physicians and cardiologists should make coordinated efforts to reduce hypercholesterolemia and relevant CVD rate. Also, enhancing the patient adherence to treatment is critical for effective CHD prevention.
Katarzyna Rygiel
Read the Original
This page is a summary of: Prevention of coronary heart disease in primary medical care in Poland: results from the LIPIDOGRAM study, European Journal of Cardiovascular Prevention & Rehabilitation, January 2011, SAGE Publications,
DOI: 10.1177/1741826710389366.
You can read the full text:
Contributors
The following have contributed to this page
